AlphAIAlphAI — Financial news for AI agents
fool.comSEP 303 min read$CNXC

Concentrix (CNXC) Q3 2026 Earnings Call Transcript

Concentrix (CNXC) reported Q3 2026 revenue of $2.45B, down 1.2%, with non-GAAP EPS at $2.92, up $0.14 YoY. Non-GAAP operating income exceeded guidance, but GAAP net loss was $988.1M due to a $1.05B goodwill impairment charge. Q4 revenue guidance is $2.41B-$2.46B, with FY 2026 revenue expected at $9.827B-$9.877B. Management highlighted AI-driven growth and debt reduction plans.

Original reporting
fool.com
Published Sep 30, 2026, 10:53 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 12:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Concentrix (CNXC) Q3 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$CNXCNeutralHigh
01

Why it matters

The earnings beat on profitability metrics contrasts with slight revenue decline, creating a nuanced market reaction.

02

Market read

First disclosure of Q3 2026 results and FY guidance, offering fresh data for traders.

03

What to watch

Potential upside from upcoming CastleHill acquisition and AI‑driven ARR growth not fully priced in.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

Concentrix (CNXC) held its Q3 2026 earnings call, providing detailed financial results and forward guidance.

Company-level read

Ticker impact

$CNXCNeutralHigh confidence
Context

Q3 2026 earnings released with $2.45B revenue, $2.92 non‑GAAP EPS and FY 2026 guidance.

Expected impact

potential modest downside as investors price in lower revenue guidance despite margin expansion

Evidence & confidence

Guidance shows 0.5% constant‑currency revenue decline and 3‑5% Q4 headwind, which may outweigh the non‑GAAP beat.

Market effects

Sector

AI‑enabled BPO services may see increased investor focus, but offshoring headwinds could temper sector enthusiasm.

Regional

U.S. tech services sector may see slight pullback; offshore competitors could benefit.

Global

Highlights broader trend of AI integration in services and the impact of offshore cost shifts worldwide.

Counterpoint

What could challenge this read

The strong non‑GAAP margin expansion and record free cash flow could outweigh modest revenue guidance, supporting a buy.

Key entities

  • Company
    Concentrix Corporation

    U.S. listed provider of customer experience services.

Read at source← All news

Also covered by

2 outlets

Related articles

SEP 30
$CNXCHighAI 8/10

Concentrix earnings analysis: questions answered and next catalysts

Concentrix Corp (CNXC) reported Q3 earnings with a $0.21 EPS beat ($2.92) but a $30M revenue miss ($2.45B vs. $2.48B est). Shares initially dropped 9.77% before recovering 3.12%. Management highlighted AI-driven revenue growth (50% of total) and cash flow strength ($218M), but revenue declines due to specific client exits and offshoring. The dividend was raised to $0.37/share. Growth is expected to return in 2028, with key catalysts including Q4 earnings and debt paydown milestones.

investing.com2 min
SEP 30
$CNXCMedAI 8/10

Why Concentrix Stock Ended Up Moving Higher Today

Concentrix (CNXC) reported fiscal Q3 revenue below estimates due to client shifts, but earnings beat expectations. CEO Christopher Caldwell attributed the shortfall to client preferences, not customer loss. The stock initially dropped but recovered, up 3% by midday. Analysts' average price target is $33.50, over 30% above current levels.

aol.com3 min
SEP 30
$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

cnbc.com2 min
SEP 30
$CNXCLow

Why Concentrix (CNXC) Stock Is Up Today

Concentrix (CNXC) stock rose 4% after reporting a Q3 net loss of $988.1M, driven by a $1.5B goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B, missing estimates. Adjusted EPS was $2.92. The company cited AI deployments and client decisions for the decline. Shares later cooled to $25.73, up 1%.

stockstory.org2 min
SEP 30
$CNXCHighAI 8/10

Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s

Concentrix Corp (NASDAQ:CNXC) shares fell 10.6% premarket after reporting mixed Q3 results, missing sales estimates and issuing weak Q4 guidance. The company also narrowed its FY26 adjusted EPS guidance and cut FY26 sales guidance below estimates. Earnings of $2.92 per share beat estimates, while sales of $2.454 billion missed expectations.

benzinga.com2 min
SEP 30
$BAMed

Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more

Boeing shares rose 2% after securing a $20B defense contract. Robinhood gained 2% with new AI features and 24/7 trading plans. Concentrix dropped 9.5% on weak earnings and guidance. Moderna fell 6% after a Citi downgrade. FormFactor rose 1% on a Deutsche Bank buy rating. Cal-Maine Foods declined 6.5% on larger-than-expected losses.

cnbc.com2 min